Ivacaftor
Número CAS
873054-44-5
Fórmula molecular
C24H28N2O3
Peso molecular
392.49
Pureza
98%
Ponto de fusão
212-215°C
Solubilidade
DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
Aparência
White to Light Brown solid
Condições de armazenamento
Refrigerator
Indicação
Cystic fibrosis
Descrição do produto

In January 2012, the US FDA approved ivacaftor for the treatment of cystic fibrosis (CF) in patients who have the G551D mutation of the CF transmembrane regulator (CFTR) and are at least 6 years old.